Enduro Genetics
PrivateLast Round
Series A
Feb 3, 2025
Total Funding Raised
$18.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Enduro Genetics is a biotechnology company that provides a patented cell reprogramming technology, Enduro Sense, which addicts cells to high production to boost yields and cut costs in biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enduro Genetics Comparables
Compare Enduro Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Biotech | 78% | |
| 21st.BIO | 78% | |
| Cultiply | 64% |
Enduro Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 3, 2025 | ||||
| Grant | Dec 17, 2024 | ||||
| Grant | Mar 8, 2023 | ||||
| Seed | Apr 7, 2022 | ||||
| Pre Seed | Dec 2, 2020 |
Enduro Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| NOON Ventures | Series A, Seed |
| Sandwater | Series A |
| Supernova Invest | Series A |
| BioInnovation Institute | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 43% MoM.
- Jun 19, 2026
Monthly visitors grew 160% MoM, reaching 1.5K.
Enduro Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enduro Genetics's valuation, stock price, and market status.
Is Enduro Genetics a public or private company?
Enduro Genetics is a private company.
What is the current stock price of Enduro Genetics?
Enduro Genetics is a private company, so its shares have no public market price. Caplight tracks Enduro Genetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enduro Genetics worth (valuation)?
Valuation information for Enduro Genetics is not publicly available.
Can I buy Enduro Genetics stock?
Enduro Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enduro Genetics's last funding round?
Enduro Genetics's most recent funding round was Series A on February 3, 2025.
Who are the main investors in Enduro Genetics?
Key investors in Enduro Genetics include NOON Ventures, Supernova Invest, BioInnovation Institute.
Will Enduro Genetics IPO soon?
No public IPO plans have been announced for Enduro Genetics.
How can I track Enduro Genetics secondary market activity?
Caplight tracks bids, offers, and trades in Enduro Genetics's shares on secondary markets.